Brief: Regenerx, Lee's Pharm announce acceleration of RGN-259 development in China
01/06/2016 13:30
June 1 (Reuters) - Regenerx Biopharmaceuticals Inc RGRX.PK
* Regenerx and lee's pharm announce acceleration of rgn-259
development in china
Source text for Eikon: ID:nPn8DDC6Ca
Further company coverage: RGRX.PK
(Bengaluru Newsroom: +1-646-223-8780)
Recent news on RegeneRx Biopharmaceuticals
See all newsBrief: Regenerx Effects Reverse Stock Split, Terminates SEC Reporting Obligations
Brief: Regenerx Receives Stockholder Approval For Reverse Stock Split
Brief: First Patient Enrolled Into U.S. Phase 3 Neurotrophic Keratitis Clinical Trial With Rgn-259
Brief: RegeneRx Publishes RGN-259 Phase 3 Clinical Trial Results
Brief: Regenerx Reports Topline Results Of Arise-3 Dry Eye Trial